Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-09-27 4:15 pm Sale | 2021-09-23 | 13D | I-Mab IMAB | HHLR Advisors, Ltd. | 16,520,560 9.300% | -2,530,000 (-13.28%) | Filing History |
| 2021-09-27 4:10 pm Purchase | 2021-04-30 | 13G | Smart Share Global Limited EM | HHLR Advisors, Ltd. | 62,627,893 14.700% | 62,627,893 (New Position) | Filing History |
| 2021-07-19 4:05 pm Sale | 2021-07-15 | 13D | Enstar Group Limited ESGR | HHLR Advisors, Ltd. | 0 0.000% | -543,487 (Position Closed) | Filing History |
| 2021-06-24 06:56 am Unchanged | 2021-06-18 | 13D | I-Mab IMAB | HHLR Advisors, Ltd. | 19,050,560 11.300% | 0 (Unchanged) | Filing History |
| 2021-04-22 09:15 am Sale | 2021-04-20 | 13D | CHINA BIOLOGIC PRODS HLDGS INC CBPO | HHLR Advisors, Ltd. | 0 0.000% | -2,962,076 (Position Closed) | Filing History |
| 2021-03-25 4:25 pm Sale | 2021-03-23 | 13D | I-Mab IMAB | HHLR Advisors, Ltd. | 19,050,560 11.300% | -3,442,042 (-15.30%) | Filing History |
| 2021-02-16 4:27 pm Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | HHLR Advisors, Ltd. | 86,603 5.700% | 86,603 (New Position) | Filing History |
| 2021-02-16 4:25 pm Purchase | 2020-12-31 | 13G | Leap Therapeutics, Inc. LPTX | HHLR Advisors, Ltd. | 371,624 6.200% | 371,624 (New Position) | Filing History |
| 2021-02-16 4:24 pm Purchase | 2020-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | HHLR Advisors, Ltd. | 2,920,023 9.200% | 1,024,135 (+54.02%) | Filing History |
| 2021-02-16 4:22 pm Sale | 2020-12-31 | 13G | VIELA BIO INC VIE | HHLR Advisors, Ltd. | 2,382,414 4.300% | -2,208,762 (-48.11%) | Filing History |
| 2021-02-16 4:20 pm Sale | 2020-12-31 | 13G | Bilibili Inc. BILI | HHLR Advisors, Ltd. | 5,067,027 2.100% | -5,148,328 (-50.40%) | Filing History |
| 2021-02-16 4:20 pm Purchase | 2020-12-31 | 13G | MINISO Group Holding Limited MNSO | HHLR Advisors, Ltd. | 60,401,152 6.800% | 60,401,152 (New Position) | Filing History |
| 2021-02-16 4:20 pm Purchase | 2020-12-31 | 13G | Root, Inc. ROOT | HHLR Advisors, Ltd. | 248,273 7.290% | 248,273 (New Position) | Filing History |
| 2021-02-16 4:19 pm Sale | 2020-12-31 | 13G | iQIYI, Inc. IQ | HHLR Advisors, Ltd. | 270,539,345 10.300% | -56,323,064 (-17.23%) | Filing History |
| 2021-02-16 4:18 pm Purchase | 2020-12-31 | 13G | Beam Therapeutics Inc. BEAM | HHLR Advisors, Ltd. | 2,966,403 5.100% | 2,966,403 (New Position) | Filing History |
| 2021-02-16 4:14 pm Purchase | 2020-12-31 | 13G | KE Holdings Inc. BEKE | HHLR Advisors, Ltd. | 176,255,685 6.600% | 176,255,685 (New Position) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | Gossamer Bio, Inc. GOSS | HHLR Advisors, Ltd. | 7,420,974 9.800% | 1,509,433 (+25.53%) | Filing History |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS | HHLR Advisors, Ltd. | 5,028,289 6.600% | 350,000 (+7.48%) | Filing History |
| 2021-02-16 4:06 pm Purchase | 2020-12-31 | 13G | Futu Holdings Limited FUTU | HHLR Advisors, Ltd. | 1,200,000 0.200% | 1,200,000 (New Position) | Filing History |
| 2021-02-16 4:06 pm Sale | 2020-12-31 | 13G | Yatsen Holding Limited YSG | HHLR Advisors, Ltd. | 68,456,810 20.100% | -1,692,084 (-2.41%) | Filing History |